Argonaute 2 drives resistance to immune checkpoint inhibitors in immunorefractory non-small cell lung cancer.
Saved in:
| Title: | Argonaute 2 drives resistance to immune checkpoint inhibitors in immunorefractory non-small cell lung cancer. |
|---|---|
| Authors: | Anobile DP; Innate Immunity in Physiology and Cancer Team, Institut Curie, PSL Research University, INSERM U932, Paris, France.; Translational Immunotherapy Team, Institut Curie, PSL Research University, INSERM U932, Paris, France., Barbar L; Innate Immunity in Physiology and Cancer Team, Institut Curie, PSL Research University, INSERM U932, Paris, France., Maucotel E; Innate Immunity in Physiology and Cancer Team, Institut Curie, PSL Research University, INSERM U932, Paris, France., Cornec A; Innate Immunity in Physiology and Cancer Team, Institut Curie, PSL Research University, INSERM U932, Paris, France., Manriquez V; Translational Immunotherapy Team, Institut Curie, PSL Research University, INSERM U932, Paris, France.; Department of Translational Research, PSL University, Institut Curie Research Center, Paris, France., Richer W; Translational Immunotherapy Team, Institut Curie, PSL Research University, INSERM U932, Paris, France.; Department of Translational Research, PSL University, Institut Curie Research Center, Paris, France., Denizeau J; Translational Immunotherapy Team, Institut Curie, PSL Research University, INSERM U932, Paris, France.; Department of Translational Research, PSL University, Institut Curie Research Center, Paris, France., Sedlik C; Translational Immunotherapy Team, Institut Curie, PSL Research University, INSERM U932, Paris, France.; Department of Translational Research, PSL University, Institut Curie Research Center, Paris, France., Bories C; Innate Immunity in Physiology and Cancer Team, Institut Curie, PSL Research University, INSERM U932, Paris, France., Couderc E; Innate Immunity in Physiology and Cancer Team, Institut Curie, PSL Research University, INSERM U932, Paris, France., Leclere R; Department of Diagnostic and Theragnostic Medicine, BioHub, Pathex, Institut Curie Research Center, Paris, France., Sobas J; Department of Diagnostic and Theragnostic Medicine, BioHub, Pathex, Institut Curie Research Center, Paris, France., Papillon E; Tolerance and Anti-tumour Immunity Team, Institut Curie, PSL Research University, INSERM U932, Paris, France., Mena Osuna R; Translational Immunotherapy Team, Institut Curie, PSL Research University, INSERM U932, Paris, France.; Department of Translational Research, PSL University, Institut Curie Research Center, Paris, France., Tosello-Boari J; Translational Immunotherapy Team, Institut Curie, PSL Research University, INSERM U932, Paris, France.; Department of Translational Research, PSL University, Institut Curie Research Center, Paris, France., Burbage M; Tolerance and Anti-tumour Immunity Team, Institut Curie, PSL Research University, INSERM U932, Paris, France., Piaggio E; Translational Immunotherapy Team, Institut Curie, PSL Research University, INSERM U932, Paris, France.; Department of Translational Research, PSL University, Institut Curie Research Center, Paris, France., Poirier EZ; Innate Immunity in Physiology and Cancer Team, Institut Curie, PSL Research University, INSERM U932, Paris, France. |
| Source: | PLoS biology [PLoS Biol] 2026 Jun 18; Vol. 24 (6), pp. e3003860. Date of Electronic Publication: 2026 Jun 18 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101183755 Publication Model: eCollection Cited Medium: Internet ISSN: 1545-7885 (Electronic) Linking ISSN: 15449173 NLM ISO Abbreviation: PLoS Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
